These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19915934)

  • 1. Establishment and characterization of an osteopontin-null cutaneous squamous cell carcinoma cell line.
    Hsieh YH; Juliana MM; Chang PL
    In Vitro Cell Dev Biol Anim; 2010 Feb; 46(2):87-91. PubMed ID: 19915934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host-derived osteopontin maintains an acute inflammatory response to suppress early progression of extrinsic cancer cells.
    Hsieh YH; Margaret Juliana M; Ho KJ; Kuo HC; van der Heyde H; Elmets C; Chang PL
    Int J Cancer; 2012 Jul; 131(2):322-33. PubMed ID: 21826648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo.
    Crawford HC; Matrisian LM; Liaw L
    Cancer Res; 1998 Nov; 58(22):5206-15. PubMed ID: 9823334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin facilitates ultraviolet B-induced squamous cell carcinoma development.
    Chang PL; Hsieh YH; Wang CC; Juliana MM; Tsuruta Y; Timares L; Elmets C; Ho KJ
    J Dermatol Sci; 2014 Aug; 75(2):121-32. PubMed ID: 24888687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing SPP1/Osteopontin (OPN) Splice Variants and Their Association to Nonmelanoma Skin Cancer by Absolute Quantification: Identification of OPN-5 Subvariants and Their Protein Coding Potential.
    Chou CF; Huang CC; Bin Dabil N; Chang PL
    Cancer Invest; 2021; 39(6-7):559-570. PubMed ID: 34043476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435.
    Shevde LA; Samant RS; Paik JC; Metge BJ; Chambers AF; Casey G; Frost AR; Welch DR
    Clin Exp Metastasis; 2006; 23(2):123-33. PubMed ID: 16830223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin shapes immunosuppression in the metastatic niche.
    Sangaletti S; Tripodo C; Sandri S; Torselli I; Vitali C; Ratti C; Botti L; Burocchi A; Porcasi R; Tomirotti A; Colombo MP; Chiodoni C
    Cancer Res; 2014 Sep; 74(17):4706-19. PubMed ID: 25035397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer.
    Feng YH; Su YC; Lin SF; Lin PR; Wu CL; Tung CL; Li CF; Shieh GS; Shiau AL
    BMC Cancer; 2019 Aug; 19(1):791. PubMed ID: 31399076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin expression in co-cultures of human squamous cell carcinoma-derived cells and osteoblastic cells and its effects on the neoplastic cell phenotype and osteoclastic activation.
    Teixeira LN; de Castro Raucci LM; Alonso GC; Coletta RD; Rosa AL; de Oliveira PT
    Tumour Biol; 2016 Sep; 37(9):12371-12385. PubMed ID: 27312487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
    Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
    Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1.
    Metge BJ; Liu S; Riker AI; Fodstad O; Samant RS; Shevde LA
    Oncology; 2010; 78(1):75-86. PubMed ID: 20215788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways.
    Courter D; Cao H; Kwok S; Kong C; Banh A; Kuo P; Bouley DM; Vice C; Brustugun OT; Denko NC; Koong AC; Giaccia A; Le QT
    PLoS One; 2010 Mar; 5(3):e9633. PubMed ID: 20224789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential osteopontin expression in lung cancer.
    Zhang J; Takahashi K; Takahashi F; Shimizu K; Ohshita F; Kameda Y; Maeda K; Nishio K; Fukuchi Y
    Cancer Lett; 2001 Oct; 171(2):215-22. PubMed ID: 11520606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of osteopontin expression and laryngeal squamous cell carcinoma infiltration and metastasis].
    Zhao Hongchun ; Wang Yanfei ; Zheng Tihua ; Che Juan ; Cao Ruijuan ; Wang Xia
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 29(17):1530-3. PubMed ID: 26647537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and inactivation of osteopontin-degrading PHEX enzyme in squamous cell carcinoma.
    Neves RL; Chiarantin GMD; Nascimento FD; Pesquero JB; Nader HB; Tersariol ILS; McKee MD; Carmona AK; Barros NMT
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):155-164. PubMed ID: 27270332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis.
    Chiu YW; Tu HF; Wang IK; Wu CH; Chang KW; Liu TY; Kao SY
    Oral Oncol; 2010 Apr; 46(4):302-6. PubMed ID: 20219412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of osteopontin reduces liver metastasis of human pancreatic cancer xenografts injected into the spleen in a mouse model.
    Ohno K; Nishimori H; Yasoshima T; Kamiguchi K; Hata F; Fukui R; Okuya K; Kimura Y; Denno R; Kon S; Uede T; Sato N; Hirata K
    Surg Today; 2010 Apr; 40(4):347-56. PubMed ID: 20339989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of hamster osteopontin and expression distribution in normal tissues and experimentally induced oral squamous-cell carcinoma.
    Jin H; Valverde P; Chen J
    Arch Oral Biol; 2006 Mar; 51(3):236-45. PubMed ID: 16095557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravital Förster resonance energy transfer imaging reveals osteopontin-mediated polymorphonuclear leukocyte activation by tumor cell emboli.
    Kamioka Y; Takakura K; Sumiyama K; Matsuda M
    Cancer Sci; 2017 Feb; 108(2):226-235. PubMed ID: 27960041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin expression is an independent factor for poor survival in oral squamous cell carcinoma: a computer-assisted analysis on TMA sections.
    Avirović M; Matušan-Ilijaš K; Damante G; Fabrro D; Cerović R; Juretić M; Grahovac B; Jonjić N; Lučin K
    J Oral Pathol Med; 2013 Sep; 42(8):620-6. PubMed ID: 23438150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.